Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ColonScan

Financiado

Cerrado

A simple to use accurate and cost effective blood test for large scale colon ca...

A simple to use accurate and cost effective blood test for large scale colon cancer screening Universal Diagnostics (UDX) is a biomedicine start-up focused on early detection of cancer using leading-edge technologies. Our mission is to make cancer a curable disease by detecting it early through an accurate, simple to use,... ver más

30/09/2018

UNIVERSAL DIAGNOST...

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

UNIVERSAL DIAGNOSTICS SOCIEDAD ANONIMA No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2018-09-30

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

UNIVERSAL DIAGNOSTICS SOCIED...

50.00K€ | Lider

HUMAN-LIKE MACHINES

323.05K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

ColoFast Developing a Non Invasive Kit for Early Colorectal Cancer De... 3M€ Cerrado

ColoDix Disruptive and high accuracy test for early colorectal cance... 4M€ Cerrado

Colodetect Development of a novel blood based diagnostic test for color... 2M€ Cerrado

RTC-2015-3850-1 Kit easy-CCR: Desarrollo de un kit de diagnóstico para la de... 669K€ Cerrado

Monomark A comparative clinical study of a stool based versus a blood... 150K€ Cerrado

SME-2015-0640 Validation of a novel, high sensitive and more efficient non... 79K€ Cerrado

Duración del proyecto: 4 meses Fecha Inicio: 2018-05-04
Fecha Fin: 2018-09-30

Líder del proyecto

UNIVERSAL DIAGNOSTICS SOCIEDAD ANONIMA No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Universal Diagnostics (UDX) is a biomedicine start-up focused on early detection of cancer using leading-edge technologies. Our mission is to make cancer a curable disease by detecting it early through an accurate, simple to use, and cost-effective diagnostic kit. During the last 5 years, UDX has been developing a mass spectrometry (MS) based metabolic analysis that allows very cost-effective and accurate detection of metabolic markers in blood, for early detection of different types of cancer. The first product of the company (the one this proposal is all about) is ColonScan: A simple, noninvasive, accurate (AUC 92%) and inexpensive, blood-based screening test to detect colorectal cancer (CRC) and adenomas (precancerous stages), allowing early detection and cancer prevention. ColonScan will be highly accurate, easily scalable worldwide, simple to use, non-invasive and inexpensive; ColonScan presents all characteristics and requirements to be adopted as CRC screening program for average risk population since, our technology can be included routinely in normal blood tests at annual or biannual medical check-ups. Moreover, the metabolomics platform developed in ColonScan project can be applied and upscaled to other types of cancer with no cost increase. CRC is the third most commonly diagnosed and leading cause of cancer death in the world, despite CRC is considered a completely preventable disease. All CRC guidelines recommends regularly (annual or biannual) screening of average risk population (50-85 years old). This represents a huge market opportunity, which according to our conservative estimations means a target population of 380 Million people and 12 Billion market opportunity. The ultimate objective of ColonScan Phase 1 project is to assess the feasibility of our business innovation project, under a commercial, technical and financial point of view to minimize any potential risk that might endanger our business plan.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores